Tumour Current Events | Tumour News | 4
|
| Page
4 of
14 |
263 Results |
|
|
|
Sort By:
Page Views | Date |
HSP90: New point of view on melanoma of the eye, at the MUHC
Ocular melanoma is rarely detected before it has grown large enough to impair vision or to metastasize. This makes it a particularly challenging disease to fight, especially since chemotherapy is not very effective. view more (2008-02-20)
Cancer cells spread by releasing 'bubbles', according to an MUHC study
A new fundamental mechanism of how tumour cells communicate has just been discovered by the team of Dr. Janusz Rak at the Research Institute of the McGill University Health Centre (MUHC) in collaboration with Dr Guha from the University of Toronto. view more (2008-04-22)
Contagious canine cancer
The source of a cancer that affects dogs around the world has been traced by scientists and vets at UCL (University College London) to a single wolf or dog, which probably lived in China or Siberia more than 250 years ago. view more (2006-08-11)
The Light Is Fighting Cancer
The light helps physicians of the Gertsen Moscow Scientific Research Oncological Institute to fight cancer. The division headed by Professor Sokolov closely collaborates with the department of optical spectroscopy, Prokhorov Institute of General Physics, Russian Academy of Sciences, headed by Professor Smirnov, Doctor of Science... view more... (2003-06-27)
Reconstruction of the lower jaw with a fibula autotrasplant
The University Hospital of the University of Navarra has carried out a complicated surgical operation on a child who had a particularly large benign tumour located in the mandibular region. The procedure involved the extraction of the lower jaw and its substitution by a bone transplant from the fibula of the patient. view more (2005-05-09)
Colorectal cancer : A new way of increasing the efficacy of chemotherapy
Inserm and CNRS research scientists and doctors at the Institut Curie have demonstrated the influence of the status - mutated or functional - of the tumour suppressor gene p53 in the response of colorectal cancer to chemotherapy. Tumours in which the p53 gene is mutated respond less well to treatment. However, by adding another agent, researchers... view more... (2004-02-27)
'Nanobodies' herald a new era in cancer therapy
Cancer, along with heart and vascular disease, is the major cause of death in the Western world. The first generation of anti-cancer drugs has already saved many lives, but because these medicines are non-specific they also often have severe side effects. Researchers at VIB (the Flanders Interuniversity Institute for Biotechnology) are now... view more... (2004-05-12)
A new radiation therapy treatment developed for head and neck cancer patients
Most head-and-neck cancers that recur locally after prior full-dose conventional radiation therapy respond to Boron Neutron Capture Therapy (BNCT). view more (2007-08-17)
First results from novel anti-angiogenic drug trial in patients
"Surprisingly effective" says French research team Frankfurt, Germany: A new drug that targets tumour blood vessels has produced a surprisingly effective response in its first patient study - shrinking the tumours in a number of patients treated so far, according to researchers carrying out the study at the Institut Gustave Roussy in Villejuif,... view more... (2002-11-17)
Increase in the reliability of brain tumour diagnosis
A team of European researchers lead by Carles Ar'°s, professor at the Department of Biochemistry and Molecular Biology of the Universitat Autònoma de Barcelona, have developed a system that facilitates the interpretation of magnetic resonance spectra of brain tumours and improves their diagnosis. It is a computer-based tool that... view more... (2004-02-09)
A new prognostic tool for gastric carcinomas? (and maybe other cancers)
A new way to identify gastric carcinoma patients with high probability of develop a more aggressive form of disease has just been described on the June issue of the journal Glycobiology. view more (2005-05-16)
UBC discovery may lead to 'smart' therapies for breast, ovarian cancer
New non-toxic and targeted therapies for metastatic breast and ovarian cancers may now be possible, thanks to a discovery by a team of researchers at the University of British Columbia. view more (2007-03-19)
Researchers find the mechanism by which cells resist chemotherapy
In his paper, to be published in The EMBO Jorunal, Dr Surrallés describes how proteins of the Fanconi/BRCA pathway recognise the presence of genetic mutations in order to repair them. view more (2007-03-05)
How Cancer Neutralises T Cell Attack
New insights into how tumours neutralise CD8 T cells, and a strategy for overcoming the tumour's response to attack. Lausanne (April 15) -- It has long been recognised that the immune system is able to recognise and destroy cancer cells, but although the immunological battle might slow the progression or spread of cancer, it's usually the cancer... view more... (2004-04-12)
New Clues For Brain Cancer Treatment Found At The ESRF
A team of researchers from the University Hospital of Grenoble (CHU - Inserm U647) and the ESRF1 has found a new treatment that improves the survival of rats with high-grade gliomas. This research was carried out at the ESRF Medical Beamline. It showed that after a year of this treatment, three rats out of 10 were considered cured, whereas... view more... (2004-04-02)
Frog molecule could provide drug treatment for brain tumours
Known as Amphinase, the molecule recognises the sugary coating found on a tumour cell and binds to its surface before invading the cell and inactivating the RNA it contains, causing the tumour to die. view more (2007-06-27)
Doctors investigating 'one stop shop' radiotherapy at time of surgery
A new radiotherapy technique that can be carried out at the time of surgery and avoids long drawn out sessions of treatment may prove better at preventing the cancer returning in the breast and also bring breast conservation surgery within the reach of women in developing countries. But, although intraoperative radiotherapy appears promising... view more... (2002-03-19)
Oxford BioMedica Obtains Approval For Trovax® To Enter Phase II Trials For Colorectal Cancer
Oxford, UK: 3 March 2003 - Oxford BioMedica (LSE:OXB) announced today that it had received ethical approval from the UK Gene Therapy Advisory Committee ('GTAC') for its therapeutic cancer vaccine, TroVax, to enter a Phase II clinical trial in patients receiving chemotherapy for colorectal cancer. The trial is planned to start within two months.... view more... (2003-03-03)
Humble yeast sheds light on promising anti-cancer drug
The humble yeast has revealed the molecular workings of an anti-cancer drug that stops the growth and spread of tumours in humans by starving their blood supply. view more (2005-10-19)
ESF workshop makes major advance in cancer radiotherapy
Radical improvements in outcome for many cancer sufferers are in prospect following one of the most significant advances in radiotherapy since x-rays were first used to treat a tumour in 1904. view more (2008-11-07)
|
|
| Page
4 of
14 |
263 Results |
|
|
|
Sort By:
Page Views | Date |
|
